July 8 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- ENTERED INTO ANTIVIRAL SARS-COV-2 SCREENING PROGRAM AGREEMENT WITH COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
- ENTERED INTO ANTIVIRAL SARS-COV-2 SCREENING PROGRAM AGREEMENT UNIVERSITY OF MELBOURNE ALSO
Source text nASXZGRbt
News: RCE Recce Pharmaceuticals Says Entered Into Antiviral Sars-Cov-2 Screening Program Agreement
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.0¢ | $56.13K | 190.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22674 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 64266 | 7 |
View Market Depth
| Last trade - 14.11pm 30/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |